New members

FACCNE Welcomes New Member RAREly Solutions: Turning Rare-Disease Science into Scalable Ventures

RAREly Solutions helps early-stage biotech and rare-disease innovators turn breakthrough science into investable, scalable companies.

FACCNE is pleased to welcome RAREly Solutions as a new member. Founded by Eleonora Guadagnin, PhD, Executive MBA, RAREly Solutions supports early-stage biotech and rare-disease innovators by bridging science and business. The firm guides teams through R&D prioritization, funding alignment, and strategic execution, helping transform breakthrough research into investable and scalable ventures across rare-disease therapeutics, mRNA, and lncRNA technologies.
 

For more information: https://rarelysolutions.com/